home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

CHI’S Second Annual Toxicity Biomarkers 2005

 
  July 07, 2005  
     
 
Cambridge Healthtech Institute, Philadelphia, Pennsylvania
September 27-28, 2005


The rising costs of drug development are putting pressure on pharmaceutical companies to reduce clinical attrition and maximize decision-making at the pre-clinical stage. One of the keys to reducing the cost and time of drug development is early and accurate safety evaluation of candidate drugs. The growing understanding of the toxicity mechanisms is creating an opportunity to develop toxicity biomarkers at the pre-clinical, clinical, and post-market stages. The Toxicity Biomarkers meeting will outline specific strategies and case studies necessary to realize and derive value from this information.
 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers: Go To http://www.healthtech.com/2005/bmk/bmx.asp for Full Information.
 
Deadline for Abstracts:
 
Registration: Go To http://www.healthtech.com/2005/bmk/bmx.asp for Full Information.
E-mail: chi@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.